Search results
Found 259 matches for
UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.
Oxford lung cancer early detection trial reaches 400 participants
Lung cancer
8 April 2024
The SCOOT study seeks current and former smokers across England to provide blood samples for ongoing research aiming to improve lung cancer diagnosis.
£1.7 million for vaccine to prevent lung cancer
Lung cancer
22 March 2024
Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.
Funding to compare imaging modalities for liver cancer detection
Liver cancer
15 March 2024
The DeLIVER team will evaluate non-contrast-enhanced MRI and compare it to standard of care ultrasound in a cohort of patients under surveillance for liver cancer.
Ultrasensitive detection of p53 cancer biomarker
15 March 2024
Professor Jason Davis and team have developed a new sensor to selectively and quantitatively measure p53 autoantibodies in the blood, levels of which are raised in a broad range of cancers.
Crowd-sourcing approach assesses current methods for improved automated detection and boundary mapping of colorectal cancer precursors
2 February 2024
A computer vision challenge was set to objectively quantify the generalisability of polyp detection and mapping algorithms, and challenge participants to innovate novel methods.
First patient recruited to MILI trial
26 January 2024
Oxford’s first precision prevention cancer trial in people with Li Fraumeni Syndrome has opened to recruitment
Challenges for colorectal cancer risk stratification in people with IBD using histology
9 January 2024
A team of pathologists were unable to validate a histology-based assessment of cancer risk in people with inflammatory bowel disease (IBD).
Oxford Centre for Early Cancer Detection Symposium 2023 – a recap
Lung cancer Myeloma OxCODE travel award QResearch SCAN pathway TAPS
14 December 2023
On Tuesday 5th December, the Oxford early cancer detection community gathered at the Mathematical Institute in Oxford to hear some highlights from OxCODE’s research in the past year and to discuss ideas for future projects.
Oxford Cancer Precision Prevention Symposium – a recap
1 December 2023
To celebrate the launch of the UK’s first CRUK clinical trials unit dedicated to cancer precision prevention in Oxford, we held a research symposium that highlighted the spectra of Cancer Precision Prevention clinical programmes across the UK.
University of Oxford Awarded £3 Million to Establish HealthTech Research Centre
16 November 2023
The Nuffield Department of Primary Care Health Sciences wins an NIHR award for a new HealthTech Research Centre (HRC) to explore innovative Health Technology to enhance community and primary care.
OxCODE researchers at the Early Detection of Cancer Conference 2023
OxCODE travel award SCAN pathway TAPS
31 October 2023
Oxford’s early detection research was featured at this annual event.
First private specialised haematology clinic and laboratory in sub-Saharan Africa launched
23 October 2023
SerenOx Africa, led by Professor Anna Schuh, aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility also aims to provide early cancer detection for high-risk patients.
Collaboration announced to develop the use of AI to evaluate Barrett’s oesophagus
6 October 2023
An agreement between Satisfai Health Inc and the University of Oxford will progress the automated assessment of Barrett’s oesophagus with the aim of determining patients most at risk of developing oesophageal cancer.
OxCODE travel awards 2023
OxCODE travel award TAPS
25 September 2023
Congratulations to James Chettle, Masato Inoue and Eoghan Mulholland who have been awarded OxCODE funds to attend this year’s Early Detection of Cancer conference in London.
MILI trial: the start of precision cancer prevention
21 September 2023
Oxford’s first precision prevention cancer trial in people with Li Fraumeni Syndrome will also shed light on the mechanisms of cancer development in the general population
Disentangling a long-standing link between inflammation and cancer progression
10 September 2023
A study led by the Mead Group has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant blood stem cells, shedding light on the progression of leukaemia.
OxCODE funding scheme awards 2023
OxCODE funding scheme
31 August 2023
Congratulations to James McCullagh, Monica Olcina, Bethan Psaila, and their collaborators who have been awarded funding in the fourth round of the OxCODE Funding Scheme.
Model to predict 10-year risk of breast cancer
QResearch
24 August 2023
A team of researchers led by Professor Julia Hippisley-Cox have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.
Double funding success to improve detection and risk classification of myeloproliferative neoplasms (MPNs)
21 August 2023
Blood Cancer UK and Cancer Research UK recognise the need and impact of artificial intelligence approaches developed by Professor Daniel Royston and Professor Jens Rittscher for early detection and assessment of these blood cancers.
Identification of a molecular signature that correlates with patient prognosis in SETD2-mutated cancers
21 August 2023
In a pan-cancer analysis spanning 24 different cancer types, researchers shed light on the relationship between SETD2, DNA methylation and cancer development.